Cargando…

Selective Inhibition of Protein Kinase C β(2) Attenuates Inducible Nitric Oxide Synthase–Mediated Cardiovascular Abnormalities in Streptozotocin-Induced Diabetic Rats

OBJECTIVE: Impaired cardiovascular function in diabetes is partially attributed to pathological overexpression of inducible nitric oxide synthase (iNOS) in cardiovascular tissues. We examined whether the hyperglycemia-induced increased expression of iNOS is protein kinase C-β(2) (PKCβ(2)) dependent...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagareddy, Prabhakara Reddy, Soliman, Hesham, Lin, Guorong, Rajput, Padmesh S., Kumar, Ujendra, McNeill, John H., MacLeod, Kathleen M.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750218/
https://www.ncbi.nlm.nih.gov/pubmed/19587355
http://dx.doi.org/10.2337/db09-0432
_version_ 1782172230183026688
author Nagareddy, Prabhakara Reddy
Soliman, Hesham
Lin, Guorong
Rajput, Padmesh S.
Kumar, Ujendra
McNeill, John H.
MacLeod, Kathleen M.
author_facet Nagareddy, Prabhakara Reddy
Soliman, Hesham
Lin, Guorong
Rajput, Padmesh S.
Kumar, Ujendra
McNeill, John H.
MacLeod, Kathleen M.
author_sort Nagareddy, Prabhakara Reddy
collection PubMed
description OBJECTIVE: Impaired cardiovascular function in diabetes is partially attributed to pathological overexpression of inducible nitric oxide synthase (iNOS) in cardiovascular tissues. We examined whether the hyperglycemia-induced increased expression of iNOS is protein kinase C-β(2) (PKCβ(2)) dependent and whether selective inhibition of PKCβ reduces iNOS expression and corrects abnormal hemodynamic function in streptozotocin (STZ)-induced diabetic rats. RESEARCH DESIGN AND METHODS: Cardiomyocytes and aortic vascular smooth muscle cells (VSMC) from nondiabetic rats were cultured in low (5.5 mmol/l) or high (25 mmol/l) glucose or mannitol (19.5 mmol/l mannitol + 5.5 mmol/l glucose) conditions in the presence of a selective PKCβ inhibitor, LY333531 (20 nmol/l). Further, the in vivo effects of PKCβ inhibition on iNOS-mediated cardiovascular abnormalities were tested in STZ-induced diabetic rats. RESULTS: Exposure of cardiomyocytes to high glucose activated PKCβ(2) and increased iNOS expression that was prevented by LY333531. Similarly, treatment of VSMC with LY333531 prevented high glucose–induced activation of nuclear factor κB, extracellular signal–related kinase, and iNOS overexpression. Suppression of PKCβ(2) expression by small interference RNA decreased high-glucose–induced nuclear factor κB and extracellular signal–related kinase activation and iNOS expression in VSMC. Administration of LY333531 (1 mg/kg/day) decreased iNOS expression and formation of peroxynitrite in the heart and superior mesenteric arteries and corrected the cardiovascular abnormalities in STZ-induced diabetic rats, an action that was also observed with a selective iNOS inhibitor, L-NIL. CONCLUSIONS: Collectively, these results suggest that inhibition of PKCβ(2) may be a useful approach for correcting abnormal hemodynamics in diabetes by preventing iNOS mediated nitrosative stress.
format Text
id pubmed-2750218
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-27502182010-10-01 Selective Inhibition of Protein Kinase C β(2) Attenuates Inducible Nitric Oxide Synthase–Mediated Cardiovascular Abnormalities in Streptozotocin-Induced Diabetic Rats Nagareddy, Prabhakara Reddy Soliman, Hesham Lin, Guorong Rajput, Padmesh S. Kumar, Ujendra McNeill, John H. MacLeod, Kathleen M. Diabetes Original Article OBJECTIVE: Impaired cardiovascular function in diabetes is partially attributed to pathological overexpression of inducible nitric oxide synthase (iNOS) in cardiovascular tissues. We examined whether the hyperglycemia-induced increased expression of iNOS is protein kinase C-β(2) (PKCβ(2)) dependent and whether selective inhibition of PKCβ reduces iNOS expression and corrects abnormal hemodynamic function in streptozotocin (STZ)-induced diabetic rats. RESEARCH DESIGN AND METHODS: Cardiomyocytes and aortic vascular smooth muscle cells (VSMC) from nondiabetic rats were cultured in low (5.5 mmol/l) or high (25 mmol/l) glucose or mannitol (19.5 mmol/l mannitol + 5.5 mmol/l glucose) conditions in the presence of a selective PKCβ inhibitor, LY333531 (20 nmol/l). Further, the in vivo effects of PKCβ inhibition on iNOS-mediated cardiovascular abnormalities were tested in STZ-induced diabetic rats. RESULTS: Exposure of cardiomyocytes to high glucose activated PKCβ(2) and increased iNOS expression that was prevented by LY333531. Similarly, treatment of VSMC with LY333531 prevented high glucose–induced activation of nuclear factor κB, extracellular signal–related kinase, and iNOS overexpression. Suppression of PKCβ(2) expression by small interference RNA decreased high-glucose–induced nuclear factor κB and extracellular signal–related kinase activation and iNOS expression in VSMC. Administration of LY333531 (1 mg/kg/day) decreased iNOS expression and formation of peroxynitrite in the heart and superior mesenteric arteries and corrected the cardiovascular abnormalities in STZ-induced diabetic rats, an action that was also observed with a selective iNOS inhibitor, L-NIL. CONCLUSIONS: Collectively, these results suggest that inhibition of PKCβ(2) may be a useful approach for correcting abnormal hemodynamics in diabetes by preventing iNOS mediated nitrosative stress. American Diabetes Association 2009-10 2009-07-08 /pmc/articles/PMC2750218/ /pubmed/19587355 http://dx.doi.org/10.2337/db09-0432 Text en © 2009 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Article
Nagareddy, Prabhakara Reddy
Soliman, Hesham
Lin, Guorong
Rajput, Padmesh S.
Kumar, Ujendra
McNeill, John H.
MacLeod, Kathleen M.
Selective Inhibition of Protein Kinase C β(2) Attenuates Inducible Nitric Oxide Synthase–Mediated Cardiovascular Abnormalities in Streptozotocin-Induced Diabetic Rats
title Selective Inhibition of Protein Kinase C β(2) Attenuates Inducible Nitric Oxide Synthase–Mediated Cardiovascular Abnormalities in Streptozotocin-Induced Diabetic Rats
title_full Selective Inhibition of Protein Kinase C β(2) Attenuates Inducible Nitric Oxide Synthase–Mediated Cardiovascular Abnormalities in Streptozotocin-Induced Diabetic Rats
title_fullStr Selective Inhibition of Protein Kinase C β(2) Attenuates Inducible Nitric Oxide Synthase–Mediated Cardiovascular Abnormalities in Streptozotocin-Induced Diabetic Rats
title_full_unstemmed Selective Inhibition of Protein Kinase C β(2) Attenuates Inducible Nitric Oxide Synthase–Mediated Cardiovascular Abnormalities in Streptozotocin-Induced Diabetic Rats
title_short Selective Inhibition of Protein Kinase C β(2) Attenuates Inducible Nitric Oxide Synthase–Mediated Cardiovascular Abnormalities in Streptozotocin-Induced Diabetic Rats
title_sort selective inhibition of protein kinase c β(2) attenuates inducible nitric oxide synthase–mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750218/
https://www.ncbi.nlm.nih.gov/pubmed/19587355
http://dx.doi.org/10.2337/db09-0432
work_keys_str_mv AT nagareddyprabhakarareddy selectiveinhibitionofproteinkinasecb2attenuatesinduciblenitricoxidesynthasemediatedcardiovascularabnormalitiesinstreptozotocininduceddiabeticrats
AT solimanhesham selectiveinhibitionofproteinkinasecb2attenuatesinduciblenitricoxidesynthasemediatedcardiovascularabnormalitiesinstreptozotocininduceddiabeticrats
AT linguorong selectiveinhibitionofproteinkinasecb2attenuatesinduciblenitricoxidesynthasemediatedcardiovascularabnormalitiesinstreptozotocininduceddiabeticrats
AT rajputpadmeshs selectiveinhibitionofproteinkinasecb2attenuatesinduciblenitricoxidesynthasemediatedcardiovascularabnormalitiesinstreptozotocininduceddiabeticrats
AT kumarujendra selectiveinhibitionofproteinkinasecb2attenuatesinduciblenitricoxidesynthasemediatedcardiovascularabnormalitiesinstreptozotocininduceddiabeticrats
AT mcneilljohnh selectiveinhibitionofproteinkinasecb2attenuatesinduciblenitricoxidesynthasemediatedcardiovascularabnormalitiesinstreptozotocininduceddiabeticrats
AT macleodkathleenm selectiveinhibitionofproteinkinasecb2attenuatesinduciblenitricoxidesynthasemediatedcardiovascularabnormalitiesinstreptozotocininduceddiabeticrats